Error: Could not add to watchlist. X
+ Watchlist

Astex Pharmaceuticals Inc

ASTX:US
Acquired
ASTX:US was acquired by 4578:JP
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.03
Market Cap (USD)
-
Shares Outstanding (m)
94.943
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Astex Pharmaceuticals, Inc. operates as a pharmaceutical company specializes in small-molecule drug discovery, development, and commercialization for oncology. The Company focuses on epigenetic therapeutics and fragment-based drug discovery.
Address
4420 Rosewood Drive
Suite 200
Pleasanton, CA 94588
United States
Phone
1-925-560-0100
  • Michael Molkentin
    CFO/Secretary
  • Robert Martin Buckland
    Chief Business Officer
  • Mohammad Azab
    President:USA Product Development/Chief Med Ofcr
  • Harren Jhoti
    President:UK Discovery Research
Show More